Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
105 hedge funds and large institutions have $262M invested in Calithera Biosciences, Inc in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 28 increasing their positions, 35 reducing their positions, and 17 closing their positions.
53% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 17
45% more capital invested
Capital invested by funds: $181M → $262M (+$81.1M)
8% more funds holding
Funds holding: 97 → 105 (+8)
1% less call options, than puts
Call options by funds: $11.6M | Put options by funds: $11.7M
20% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.76M |
| 2 |
BlackRock
New York
|
+$2.37M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.34M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.16M |
| 5 |
TCMG
TSP Capital Management Group
Summit,
New Jersey
|
+$896K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.88M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.7M |
| 3 |
Renaissance Technologies
New York
|
-$3.67M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$1.86M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$1.31M |
CALA Hedge Fund Activity: Q4 2020 in Review
105 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2020, worth a combined $262M — up 45% from $181M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new CALA positions and 17 closed out — a net gain of 9 holders — while 28 added to existing stakes and 35 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $8.76M. The largest seller was Point72 Asset Management, cutting an estimated $8.88M.
- 105 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2020, up from 97 in Q3 2020.
- Funds reported $262M of Calithera Biosciences, Inc stock for Q4 2020, up 45% quarter-over-quarter.
- 26 funds opened new Calithera Biosciences, Inc positions in Q4 2020 and 17 closed out, a net change of +9 holders.
- The largest Calithera Biosciences, Inc buyer in Q4 2020 was Adage Capital Partners, an estimated $8.76M added.
- The largest Calithera Biosciences, Inc seller in Q4 2020 was Point72 Asset Management, an estimated $8.88M sold.
Based on aggregated 13F filings for Q4 2020.